Activity No. 5 Drug Information Sources
Activity No. 5 Drug Information Sources
:4
PROFESSOR:Maam Jennybelle Bugayong RPh
DATE OF SUBMISSION: March 28, 2021
LEADER:Santos, Karl C.
GROUP MEMBERS:
Buenconsejo, Jovelie
Obiefune, Martha
Vinoya, Jocelyn
ACTIVITY NO. 5
DRUG INFORMATION SOURCES
I. OBJECTIVES
ADVANTAGES DISADVANTAGES
1.PRIMARY • Most current evidence • May not lead one to
• Provide data on new best decision because of
drugs limited scope
• Can personally assess • Data can be poor or
validity of studies controversial
• Every study has
limitations
• Too complex for
patients
2.SECOND • Can construct • Often require more
searches to find specific expertise to use than
information at high primary or tertiary
granularity resources
• Retrieved references
must be filtered for
quality
• Must track down
resources before
looking for answers
• Too complex for
patients • generally
interpretations of a
study and may be a
misinterpretation of
important information.
Pharmacists should
obtain and evaluate the
original article because
abstracts may not
include enough
information to critically
evaluate the study.
3.TERTIARY • Provide • Usually at least 2
comprehensive years out of date by
information publication
• Information reflects • High dependency on
views of multiple interpretation of
experts in field authors ,Pharmacists
• Fast, easy to use, and can address this by
may be good for consulting at least 2
patients tertiary resources
2. Cut/copy and paste (download) one (1) publication that represents each
drug information source.
Conclusion:
Medicine users reported receiving medicine information from many sources.
The most commonly used sources were perceived as the most reliable, but
their reliability did not seem to depend on age.
References:
https://www.comgyanendrarjoshi/drug-information-resources-29833522
https://www.who.int/medicines/publications/druginformation/en/